Results 251 to 260 of about 939,420 (304)
Some of the next articles are maybe not open access.
2012
Current combinations of surgical therapy, radiotherapy and chemotherapy regimens do not significantly improve long-term survival of the patients with malignant glioma. Cancer immunotherapy against malignant glioma is a potentially new therapeutic strategy that primes a patient's immune system to attack glioma cells.
openaire +2 more sources
Current combinations of surgical therapy, radiotherapy and chemotherapy regimens do not significantly improve long-term survival of the patients with malignant glioma. Cancer immunotherapy against malignant glioma is a potentially new therapeutic strategy that primes a patient's immune system to attack glioma cells.
openaire +2 more sources
Peptide vaccines in immunocontraception.
Current opinion in molecular therapeutics, 2004Vaccines have been used successfully to treat and eradicate infectious diseases; this has encouraged a major drive towards development of contraceptive vaccines (immunocontraception) as an additional method against rising human and animal populations.
Ferro, Valerie A, Mordini, Emilio
openaire +2 more sources
Antitumor vaccination using peptide based vaccines
Immunology Letters, 2000Cytotoxic T Lymphocytes (CTLs) recognize Major Histocompatibility Complex (MHC) class I in complex with peptides. Peptides derived from Tumor Associated Antigens (TAAs) are therefore targets for tumor rejection. A number of TAAs were identified in the last decade from human and murine tumors.
L, Eisenbach, E, Bar-Haim, K, El-Shami
openaire +2 more sources
Lipo-Peptides/Saccharides for Peptide Vaccine Delivery
2013A subunit vaccine is a vaccine that contains only the minimal microbial elements. Despite the fact that elimination of redundant components brings several advantages, it also removes the “danger signal” necessary to trigger the desired immune response. To overcome this problem, adjuvants (immunostimulants) have been widely used in vaccine formulations.
Skwarczynskim, Mariusz +2 more
openaire +3 more sources
Peptide Vaccine Against Paracoccidioidomycosis
2017The chapter reviews methods utilized for the isolation and characterization of a promising immunogen candidate, aiming at a human vaccine against paracoccidioidomycosis. Peptide P10 carries a T-CD4+ epitope and was identified as an internal sequence of the major diagnostic antigen known as gp43 glycoprotein.
Carlos P, Taborda, Luiz R, Travassos
openaire +2 more sources
Peptide Vaccines and Peptide Therapeutics
2012Peptide vaccines and Peptide therapeutics are increasingly entering into the focus of pharmaceutical companies. This section is intended to give a broad overview of areas of law that are particularly relevant to the patenting of peptide vaccines and therapeutic peptides as products and in compositions.
Ulrich Storz +2 more
openaire +1 more source
Immune peptide enhancement of peptide based vaccines
Frontiers in Bioscience, 2005Vaccines optimize the presentation of an immunogen to the immune system, oftentimes enhancing or replacing the natural activators of antigen presenting cells in order to promote the delivery and the response of T and B lymphocytes to the immunogen.
openaire +2 more sources